FMC Corporation (FMC) Balance Sheet

Total assets contracted from about $12.2B to $7.9B while total liabilities remained near $7.9B, so the shrinkage has come almost entirely from the equity side rather than from deleveraging. Retained earnings dropping from $6.7B to $1.4B indicates that the writedown trajectory is structural in nature, not a one-quarter event. Investors should monitor whether further impairments push equity deeper into negative territory, which would constrain financing flexibility.

Total debt has stayed in a range of roughly $3.5B to $4.7B, so the leverage increase is driven primarily by the equity denominator rather than new borrowing. Because the 2.00 ratio reported in 2025Q4 conflicts with the 452.24 reading in the latest quarter, the leverage metric itself appears unreliable and should be reconciled before use in credit assessment. Refinancing exposure on roughly $4.3B of debt remains a key question given weakened cash generation.

Cash rose from $390.9M in the prior quarter, though this increase may reflect working capital unwinds rather than durable earnings. The current ratio has trended down from 1.64 in 2024Q4 to 1.29 to 1.66 across recent quarters, indicating a modest but uneven erosion of short-term coverage. Liquidity headroom likely depends on continued inventory conversion, which carries execution risk in the current channel environment.

The reduction in goodwill points to write-downs of acquired intangibles, which lowers future amortization drag but also signals that prior acquisition assumptions have not held. PP&E falling by roughly half is consistent with asset impairments or disposals rather than normal depreciation alone. Investors should monitor whether remaining goodwill of $2.0B faces further impairment risk if the recovery trajectory disappoints.